Blood disorders
Lymphoma in Nanjing
南京 淋巴瘤
6 hospitals in Nanjing
Order: papers led on lymphoma, 2021–2025, then A–Z. Research activity, not a rating of care.
Only hospitals listed for lymphoma: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Nanjing may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.
- 81 papers led
- 20 papers ledNo open trial led
- 7 papers ledNo open trial led
- 6 papers ledNo open trial led
- 6 papers ledNo open trial led
- 5 papers ledNo open trial led
Lymphoma in every city Nanjing on the disease page, with the national map
open trials on lymphoma with a hospital in Nanjing
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with a listed hospital in Nanjing as lead sponsor or study site. 19 of them are led by a hospital in Nanjing. Check the registry for the current status. Whether someone can take part is decided by the study team.
Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.
- RecruitingA Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
- Phase
- Phase 3
- Started
- 2026-03
- Posted
- Registry
- NCT07409428
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 42 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Nanchang, Nanjing, Nanning, Qingdao, Quanzhou, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Xi'an, Xiamen, Xuzhou, Zhengzhou
- RecruitingPD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.
- Phase
- Phase 2
- Started
- 2026-02
- Posted
- Registry
- NCT07410520
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingEfficacy and Safety of Zanubrutinib, Rituximab, and Lenalidomide (ZR²) in Combination With Tislelizumab for Relapsed/Refractory Follicular Lymphoma
- Phase
- Phase 2
- Started
- 2026-02
- Posted
- Registry
- NCT07418190
Age 18 years to 75 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingAssessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)
- Phase
- Phase 1/Phase 2
- Started
- 2026-04
- Posted
- Registry
- NCT07496229
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 11 listed hospitals as study sitesChengdu, Chongqing, Fuzhou, Nanjing, Nanning, Shanghai, Taiyuan, Wenzhou, Wuhan, Zhengzhou
- RecruitingEfficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes
- Phase
- Phase 2
- Started
- 2026-06
- Posted
- Registry
- NCT07608978
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL
- Phase
- Phase 2
- Started
- 2026-07
- Posted
- Registry
- NCT07609823
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteNanjing
- RecruitingOrelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With Treatment-Naïve Mantle Cell Lymphoma (MCL)
- Phase
- Phase 2
- Started
- 2026-07
- Posted
- Registry
- NCT07719556
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteChangzhou, Nanjing
- RecruitingA Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
- Phase
- Phase 3
- Started
- 2025-03
- Posted
- Registry
- NCT06742996
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Linyi, Nanchang, Nanjing, Qingdao, Shanghai, Shenyang, Wenzhou, Wuhan, Xuzhou, Zhengzhou
- RecruitingUB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
- Phase
- Phase 1
- Started
- 2025-04
- Posted
- Registry
- NCT06743503
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesNanjing, Tianjin
- RecruitingClinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
- Phase
- Phase 2
- Started
- 2025-03
- Posted
- Registry
- NCT06854445
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesChangsha, Dalian, Hangzhou, Harbin, Jinan, Lanzhou, Luzhou, Nanchang, Nanjing, Nanning, Shijiazhuang, Suzhou, Taiyuan, Wuhan, Wuhu, Xi'an, Xiamen, Zhengzhou
- RecruitingA Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
- Phase
- Phase 3
- Started
- 2025-06
- Posted
- Registry
- NCT06943872
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 28 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hohhot, Jinan, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Shenyang, Shijiazhuang, Tianjin, Wuhan, Wuxi, Xiamen, Yangzhou
- RecruitingVenetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy
- Phase
- Phase 2
- Started
- 2025-12
- Posted
- Registry
- NCT06958705
Age 18 years to 80 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)
- Phase
- Phase 2
- Started
- 2025-08
- Posted
- Registry
- NCT07082686
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 27 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Tianjin, Urumqi, Wuhan, Xi'an, Zhengzhou
- RecruitingFixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular Lymphoma
- Phase
- N/A
- Started
- 2025-07
- Posted
- Registry
- NCT07126678
Age 18 years to 75 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
- Phase
- Phase 3
- Started
- 2025-09
- Posted
- Registry
- NCT07139873
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesNanjing, Tianjin
- RecruitingPA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
- Phase
- Phase 2
- Started
- 2025-09
- Posted
- Registry
- NCT07188610
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 15 listed hospitals as study sitesBeijing, Chengdu, Guangzhou, Hangzhou, Hefei, Nanjing, Shanghai, Suzhou, Tianjin, Wuhan, Xuzhou, Zhengzhou
- RecruitingA Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
- Phase
- Phase 2
- Started
- 2025-11
- Posted
- Registry
- NCT07189065
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 38 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Hangzhou, Hefei, Linyi, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Suzhou, Taiyuan, Tianjin, Wuhan, Xiamen, Xuzhou, Zhengzhou
- RecruitingOrelabrutinib Combined With Zebetuzumab and Lenalidomide for the Treatment of Newly Diagnosed MZL
- Phase
- Phase 2
- Started
- 2025-08
- Posted
- Registry
- NCT07208981
Age 18 years to 75 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingThe Efficacy and Safety of Glofitamab in Combination With PD-1 Antibody and Lenalidomide in Patients With Relapsed/Refractory Large B-cell Lymphoma (LBCL) With TP53 Aberrations: A Prospective, Multicenter, Phase II Clinical Study
- Phase
- Phase 2
- Started
- 2025-09
- Posted
- Registry
- NCT07240194
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingOrelabrutinib Combined With Rituximab ± Lenalidomide in Response-Adapted Stratified Therapy for Untreated MZL
- Phase
- Phase 2
- Started
- 2025-04
- Posted
- Registry
- NCT07448324
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL
- Phase
- Phase 3
- Started
- 2024-05
- Posted
- Registry
- NCT06363994
Age 60 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 31 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Luoyang, Nanchang, Nanjing, Ningbo, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Urumqi, Wuhan, Xi'an, Zhengzhou
- RecruitingICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)
- Phase
- Phase 2/Phase 3
- Started
- 2024-05
- Posted
- Registry
- NCT06378138
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 43 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Hangzhou, Hefei, Huai'an, Jinan, Lanzhou, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Urumqi, Wuhan, Xi'an, Xiamen, Yichang, Zhengzhou, Zunyi
- RecruitingDZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
- Phase
- Phase 2
- Started
- 2024-04
- Posted
- Registry
- NCT06539182
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteNanjing
- RecruitingChidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes
- Phase
- Phase 2
- Started
- 2024-08
- Posted
- Registry
- NCT06891157
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingLinperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL
- Phase
- Phase 2
- Started
- 2024-12
- Posted
- Registry
- NCT07195799
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
- Phase
- Phase 3
- Started
- 2024-05
- Posted
- Registry
- NCT07234162
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 35 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Lanzhou, Linyi, Nanjing, Nanning, Shanghai, Shenyang, Taiyuan, Tianjin, Wenzhou, Wuhan, Xi'an, Xiamen, Zhengzhou
- RecruitingA Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma
- Phase
- Phase 1/Phase 2
- Started
- 2023-02
- Posted
- Registry
- NCT05800977
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 14 listed hospitals as study sitesBeijing, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing, Shanghai, Tianjin, Zhengzhou
- RecruitingA Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL
- Phase
- Phase 3
- Started
- 2023-06
- Posted
- Registry
- NCT05931263
Age 18 years to 65 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
- Phase
- Phase 3
- Started
- 2023-12
- Posted
- Registry
- NCT06136559
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 27 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Haikou, Hangzhou, Hefei, Jinan, Nanchang, Nanjing, Nanning, Taiyuan, Tianjin, Urumqi, Wuhan, Xuzhou, Zhengzhou
- RecruitingTreatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
- Phase
- Phase 1/Phase 2
- Started
- 2022-05
- Posted
- Registry
- NCT05294731
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Nanchang, Nanjing, Qingdao, Shanghai, Suzhou, Taiyuan, Wenzhou, Wuhan, Zhengzhou
- RecruitingEfficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- Phase
- Phase 2
- Started
- 2021-04
- Posted
- Registry
- NCT04728893
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Nanchang, Nanjing, Nanning, Shanghai, Tianjin, Wuhan, Xuzhou, Zhengzhou
- RecruitingEvaluate the Safety and Clinical Activity of HH2853
- Phase
- Phase 1/Phase 2
- Started
- 2020-09
- Posted
- Registry
- NCT04390737
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 15 listed hospitals as study sitesBeijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Nanjing, Nanning, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Zhengzhou
- RecruitingStudy of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL
- Phase
- Phase 1/Phase 2
- Started
- 2020-08
- Posted
- Registry
- NCT04494503
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Changchun, Changsha, Chongqing, Guangzhou, Guiyang, Hangzhou, Nanchang, Nanjing, Nanning, Shanghai, Shijiazhuang, Suzhou, Tianjin, Wuhan
- RecruitingA Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- Phase
- Phase 1
- Started
- 2018-04
- Posted
- Registry
- NCT03460977
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 6 listed hospitals as study sitesChangsha, Chengdu, Guangzhou, Nanjing, Wenzhou
- Not yet recruitingSHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma
- Phase
- Phase 2
- Started
- 2026-02
- Posted
- Registry
- NCT07347288
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingPirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL
- Phase
- Phase 2
- Started
- 2026-07
- Posted
- Registry
- NCT07744724
Age 18 years to 65 years (registered criteria)
Led by Changzhou No.2 People's Hospital; 1 listed hospital as study siteChangzhou, Nanjing
- Not yet recruitingPirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL
- Phase
- Phase 2
- Started
- 2026-07
- Posted
- Registry
- NCT07744737
Age 18 years to 80 years (registered criteria)
Led by Changzhou No.2 People's Hospital; 1 listed hospital as study siteChangzhou, Nanjing
- Not yet recruitingPirtobrutinib+Sonrotoclax(PS) Regimen in the Treatment of B-Cell Lymphoma
- Phase
- Phase 2
- Started
- 2026-08
- Posted
- Registry
- NCT07744750
Age 18 years to Not stated (registered criteria)
Led by Changzhou No.2 People's Hospital; 1 listed hospital as study siteChangzhou, Nanjing
- Not yet recruitingThe Efficacy of CAPCT in Patients With PTCL
- Phase
- Phase 2
- Started
- 2026-08
- Posted
- Registry
- NCT07746245
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingR-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma
- Phase
- N/A
- Started
- 2026-08
- Posted
- Registry
- NCT07764601
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesChangzhou, Nanjing
- Not yet recruitingA Phase 3 Study to Compare the Efficacy of ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r/r MCL).
- Phase
- Phase 3
- Started
- 2026-10
- Posted
- Registry
- NCT07784101
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 24 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Kunming, Nanjing, Shanghai, Shenyang, Shijiazhuang, Tianjin, Wuhan, Xi'an, Zhengzhou
- Not yet recruitingGlofitamab Plus Gemcitabine and Oxaliplatin (GemOx) in Relapsed or Refractory Primary and Secondary Central Nervous System Lymphoma
- Phase
- Phase 2
- Started
- 2026-11
- Posted
- Registry
- NCT07888621
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingOrelabrutinib Plus ICP 248 vs Orelabrutinib for Relapsed/Refractory Marginal Zone Lymphoma
- Phase
- Phase 3
- Started
- 2026-10
- Posted
- Registry
- NCT07896590
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 40 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Lanzhou, Luoyang, Nanchang, Nanjing, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Xi'an, Xiamen, Zhengzhou
- Not yet recruitingBrentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS
- Phase
- Phase 2
- Started
- 2025-09
- Posted
- Registry
- NCT06925555
Age 18 years to 70 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingRN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies
- Phase
- Phase 1
- Started
- 2025-08
- Posted
- Registry
- NCT07113496
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingEvaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma
- Phase
- Phase 3
- Started
- 2025-11
- Posted
- Registry
- NCT07187960
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 19 listed hospitals as study sitesBeijing, Chongqing, Guiyang, Haikou, Lanzhou, Linyi, Nanchang, Nanjing, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Xi'an, Yantai, Zhengzhou
- Not yet recruitingMolecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement
- Phase
- Phase 2
- Started
- 2024-10
- Posted
- Registry
- NCT06594432
Age 18 years to 80 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingA Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma
- Phase
- N/A
- Started
- 2022-06
- Posted
- Registry
- NCT05343377
Age 18 years to 80 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Disease research in Nanjing
Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.
A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.
| Cancer | Blood disorders | Other diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | Nasopharyngeal carcinoma | Oesophageal squamous cell carcinoma | Hepatocellular carcinoma | Stomach cancer | Lung cancer | Pancreatic cancer | Breast cancer | Glioma | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Multiple myeloma | B-cell acute lymphoblastic leukaemia | Aplastic anaemia | Haemophagocytic lymphohistiocytosis | Lymphoma | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | Neuromyelitis optica spectrum disorder | IgG4-related disease | Myasthenia gravis | Moyamoya disease | Wilson disease | Biliary atresia | Coronary heart disease | Congenital heart disease | Scoliosis | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency | Shortlist |
| Affiliated BenQ Hospital of Nanjing Medical University南京明基医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Brain Hospital of Nanjing Medical University南京脑科医院 | none | none | none | none | 45 | none | none | 21 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | 2 | none | none | none | none | none | 5 | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Eye Hospital of Nanjing Medical University南京医科大学眼科医院 | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Hospital of Nanjing University南京大学医学院附属鼓楼医院 | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Hospital of Nanjing University of Chinese Medicine南京中医药大学附属医院 | none | none | none | 21 | none | 18 | none | none | none | none | none | 2 | 0 | none | none | none | none | none | none | 6 | none | none | none | none | none | none | none | none | none | none | none | 6 | none | none | none | none | none | 3 | none | none | none | none | none | none | none | none | 1 | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Hospital, Nanjing Medical University南京医科大学附属口腔医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | |
| Affiliated Hospital, Nanjing University of Chinese Medicine江苏省中西医结合医院 | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Hospital, Nanjing University of Traditional Chinese Medicine江苏省中医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | 1 | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Jiangning Hospital, Nanjing Medical University南京市江宁医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Jiangsu Shengze Hospital of Nanjing Medical University江苏盛泽医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Lianyungang Hospital of Xuzhou Medical University连云港市第一人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | 4 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated People's Hospital of Jiangsu University江苏大学附属人民医院 | none | none | none | 21 | none | none | none | none | none | none | none | 1 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Yancheng Hospital, Southeast University盐城市第三人民医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Children's Hospital of Nanjing Medical University南京市儿童医院 | none | none | none | none | none | none | none | none | 3 | none | none | 1 | none | 151 open | none | none | 1 | none | none | none | none | 0 | none | none | none | none | none | none | none | none | 9 | none | 23 | none | 1 | none | none | 0 | none | none | none | 0 | none | 0 | 2 | 0 | 1 | 0 | none | none | none | none | none | 9 | none | none | 0 | none | none | none | none | |
| Fourth Affiliated Hospital of Nanjing Medical University南京医科大学第四附属医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Gaochun People's Hospital南京市高淳人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jiangsu Cancer Hospital江苏省肿瘤医院 | 141 open | 252 open | 16 | 26 | 1233 open | 6 | 471 open | 15 | none | none | none | 0 | 0 | none | none | none | none | none | none | 6 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | |
| JiangSu Provincce Hospital江苏省人民医院 | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jiangsu Province Hospital江苏省人民医院(南医大一附院) | 11 | 368 open | 1175 open | 19923 open | 2335 open | 914 open | 25025 open | 59 | none | 0 | 1 | 4 | 141 open | 82 open | 0 | 246 open | 01 open | 9 | 22 | 8119 open | 1 | 0 | none | none | none | none | none | 4 | 33 open | none | none | 10115 open | 18 | none | none | 2 | none | 10 | none | 4 | none | 1 | none | 1 | 0 | none | 2 | 1 | none | 1 | 0 | 1 | none | 0 | 0 | 0 | 2 | 1 | none | none | none | |
| Jiangsu Provincial People's Hospital江苏省人民医院(南京医科大学第一附属医院) | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jiangyin Hospital, Nanjing University of Chinese Medicine江阴市中医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jinling Hospital东部战区总医院(金陵医院) | none | 9 | 231 open | 201 open | 76 | 113 open | 19 | 24 | none | 0 | none | 14 | 0 | none | none | 41 open | none | none | none | 5 | none | none | 0 | 1 | none | none | 01 open | none | none | none | none | 242 open | 2 | none | none | none | none | 2 | none | 2 | none | none | none | none | none | 5 | 10 | none | none | 0 | none | none | none | 0 | 0 | none | 1 | none | none | none | none | |
| Nanjing Bayi Hospital中国人民解放军第八一医院 | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Chest Hospital | none | none | none | none | 25 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Drum Tower Hospital南京鼓楼医院 | 2 | 13 | 952 open | 1133 open | 811 open | 635 open | 45 | 18 | none | none | none | 8 | 12 | 1 | none | 17 | none | none | none | 20 | none | 2 | none | none | none | 0 | none | 2 | 7 | none | none | 121 open | 8 | 821 open | none | 1 | none | 31 | none | 0 | none | 0 | none | none | 0 | none | 3 | none | none | 0 | 1 | 1 | none | none | 0 | 1 | none | none | none | none | none | |
| Nanjing Drum Town Hospital | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing First Hospital南京市第一医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Jiangbei Hospital南京江北医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Pukou District Hospital南京市浦口人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Second Hospital南京市第二医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | 3 | 0 | none | none | none | none | none | none | none | none | none | |
| Nanjing Stomatological Hospital南京市口腔医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Tianyinshan Hospital南京天印山医院 | none | none | 11 open | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Second Affiliated Hospital of Nanjing Medical University南京医科大学第二附属医院 | 0 | none | 191 open | 12 | 23 | 61 open | none | none | none | none | 1 | 3 | 2 | 1 | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | 8 | none | none | none | none | 1 | 1 | none | 1 | none | none | none | none | 1 | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Second Hospital, Nanjing University of Chinese Medicine江苏省第二中医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | 3 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | |
| Shuyang Hospital, Nanjing University of Chinese Medicine沭阳县中医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Sir Run Run Hospital南京医科大学附属逸夫医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Third Affiliated Hospital of Nanjing University of Chinese Medicine南京市中医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | 16 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Women's Hospital, Nanjing Medical University南京市妇幼保健院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | 4 | none | none | none | none | none | none | none | none | 1 | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Yancheng First Hospital, Nanjing University盐城市第一人民医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Yancheng TCM Hospital, Nanjing University of Chinese Medicine盐城市中医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Zhongda Hospital, Southeast University东南大学附属中大医院 | none | 18 | 599 open | 211 open | 47 | 22 | 24 | 12 | none | 1 | 0 | 3 | 1 | 2 | 2 | 4 | 0 | none | none | 7 | none | none | none | 1 | none | none | none | none | none | none | none | 34 | 3 | 2 | none | none | none | 1 | none | 1 | none | 0 | none | none | none | none | 3 | none | none | none | 1 | none | 1 | none | none | none | none | none | none | none | none | |
Column labels are short names. Choose one to open that disease in Nanjing.
- Hepatoblastoma 3
- Osteosarcoma 1
- Neuroblastoma 151 open
- B-cell acute lymphoblastic leukaemia 1
- Haemophilia A 0
- Biliary atresia 9
- Congenital heart disease 23
- Anti-NMDA receptor encephalitis 1
- Idiopathic pulmonary fibrosis 0
- Fabry disease 0
- Duchenne muscular dystrophy 0
- Behçet disease 2
- Alport syndrome 0
- IgA nephropathy 1
- Gaucher disease 0
- Hirschsprung disease 9
- Familial adenomatous polyposis 0
- Nasopharyngeal carcinoma 141 open
- Oesophageal squamous cell carcinoma 252 open
- Hepatocellular carcinoma 16
- Stomach cancer 26
- Lung cancer 1233 open
- Pancreatic cancer 6
- Breast cancer 471 open
- Glioma 15
- Osteosarcoma 0
- Gastrointestinal stromal tumour 0
- Lymphoma 6
- Idiopathic pulmonary fibrosis 0
- Familial adenomatous polyposis 0
- Nasopharyngeal carcinoma 11
- Oesophageal squamous cell carcinoma 368 open
- Hepatocellular carcinoma 1175 open
- Stomach cancer 19923 open
- Lung cancer 2335 open
- Pancreatic cancer 914 open
- Breast cancer 25025 open
- Glioma 59
- Retinoblastoma 0
- Chordoma 1
- Osteosarcoma 4
- Gastrointestinal stromal tumour 141 open
- Neuroblastoma 82 open
- Ewing sarcoma 0
- Multiple myeloma 246 open
- B-cell acute lymphoblastic leukaemia 01 open
- Aplastic anaemia 9
- Haemophagocytic lymphohistiocytosis 22
- Lymphoma 8119 open
- Beta thalassaemia 1
- Haemophilia A 0
- Myasthenia gravis 4
- Moyamoya disease 33 open
- Coronary heart disease 10115 open
- Congenital heart disease 18
- Takayasu arteritis 2
- Idiopathic pulmonary fibrosis 10
- Amyotrophic lateral sclerosis 4
- Fabry disease 1
- Duchenne muscular dystrophy 1
- Behçet disease 0
- IgA nephropathy 2
- Gaucher disease 1
- Osteogenesis imperfecta 1
- Primary biliary cholangitis 0
- Primary sclerosing cholangitis 1
- Hirschsprung disease 0
- Inherited epidermolysis bullosa 0
- Hereditary angioedema 0
- Familial adenomatous polyposis 2
- Leber hereditary optic neuropathy 1
- Oesophageal squamous cell carcinoma 9
- Hepatocellular carcinoma 231 open
- Stomach cancer 201 open
- Lung cancer 76
- Pancreatic cancer 113 open
- Breast cancer 19
- Glioma 24
- Retinoblastoma 0
- Osteosarcoma 14
- Gastrointestinal stromal tumour 0
- Multiple myeloma 41 open
- Lymphoma 5
- Atypical haemolytic uraemic syndrome 0
- Thrombotic thrombocytopenic purpura 1
- IgG4-related disease 01 open
- Coronary heart disease 242 open
- Congenital heart disease 2
- Idiopathic pulmonary fibrosis 2
- Amyotrophic lateral sclerosis 2
- Alport syndrome 5
- IgA nephropathy 10
- Osteogenesis imperfecta 0
- Hirschsprung disease 0
- Inherited epidermolysis bullosa 0
- Familial adenomatous polyposis 1
- Nasopharyngeal carcinoma 2
- Oesophageal squamous cell carcinoma 13
- Hepatocellular carcinoma 952 open
- Stomach cancer 1133 open
- Lung cancer 811 open
- Pancreatic cancer 635 open
- Breast cancer 45
- Glioma 18
- Osteosarcoma 8
- Gastrointestinal stromal tumour 12
- Neuroblastoma 1
- Multiple myeloma 17
- Lymphoma 20
- Haemophilia A 2
- Neuromyelitis optica spectrum disorder 0
- Myasthenia gravis 2
- Moyamoya disease 7
- Coronary heart disease 121 open
- Congenital heart disease 8
- Scoliosis 821 open
- Takayasu arteritis 1
- Idiopathic pulmonary fibrosis 31
- Amyotrophic lateral sclerosis 0
- Fabry disease 0
- Behçet disease 0
- IgA nephropathy 3
- Osteogenesis imperfecta 0
- Primary biliary cholangitis 1
- Primary sclerosing cholangitis 1
- Inherited epidermolysis bullosa 0
- Hereditary angioedema 1
- Nasopharyngeal carcinoma 0
- Hepatocellular carcinoma 191 open
- Stomach cancer 12
- Lung cancer 23
- Pancreatic cancer 61 open
- Chordoma 1
- Osteosarcoma 3
- Gastrointestinal stromal tumour 2
- Neuroblastoma 1
- Thrombotic thrombocytopenic purpura 1
- Coronary heart disease 8
- Hepatic echinococcosis 1
- Idiopathic pulmonary fibrosis 1
- Amyotrophic lateral sclerosis 1
- Behçet disease 1
- IgA nephropathy 1
- Oesophageal squamous cell carcinoma 18
- Hepatocellular carcinoma 599 open
- Stomach cancer 211 open
- Lung cancer 47
- Pancreatic cancer 22
- Breast cancer 24
- Glioma 12
- Retinoblastoma 1
- Chordoma 0
- Osteosarcoma 3
- Gastrointestinal stromal tumour 1
- Neuroblastoma 2
- Ewing sarcoma 2
- Multiple myeloma 4
- B-cell acute lymphoblastic leukaemia 0
- Lymphoma 7
- Thrombotic thrombocytopenic purpura 1
- Coronary heart disease 34
- Congenital heart disease 3
- Scoliosis 2
- Idiopathic pulmonary fibrosis 1
- Amyotrophic lateral sclerosis 1
- Fabry disease 0
- IgA nephropathy 3
- Primary biliary cholangitis 1
- Congenital diaphragmatic hernia 1
Other cities nearby
Straight-line distance from the city centre; counts are hospitals listed for lymphoma.
Counts are listed hospitals only, not every hospital in each city.
Where these numbers come from
Papers
English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions
Trials
ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Nanjing on ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.